Sort
40,608 grants matching “prostate cancer”
Immunogenomic determinants of response and resistance to neoadjuvant anti-PD-1 in resectable NSCLC
$374,578Kellie Nicole Smith · Johns Hopkins University · R37 · FY2022 · CA
Mechanisms by which histone methyltransferases regulate nuclear receptor activity and response to therapy in hormone-driven tumors.
$374,578Eneda Toska · Johns Hopkins University · R01 · FY2025 · CA
Distributed knowledge-based platform for radiotherapy plan quality control
$374,577James D Murphy · University Of California, San Diego · R01 · FY2022 · HS
Quality of Life in Prostate Cancer Project
$374,573Christine Sheehan Brennan · Lsu Health Sciences Center · R15 · FY2010 · CA
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells
$374,560Benjamin Tycko · Hackensack University Medical Center · R33 · FY2019 · CA
Prostate Boundary Detection in Ultrasound Images
$374,519Insightful Corporation · R44 · FY2002 · AG
Development and Validation of a Novel Biomarker Assay for Cancer Diagnostics
$374,500Katri S Selander · Blondin Bioscience, Llc · R43 · FY2016 · TR
Development and Validation of a Novel Biomarker Assay for Cancer Diagnostics
$374,500Katri S Selander · Blondin Bioscience, Llc · R43 · FY2015 · TR
Towards Understanding Prostate Cancer Heterogeneity
$374,488Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · CA
Endocrine disruptors: AR regulation and prostate cancer
$374,471Karen E Knudsen · Thomas Jefferson University · R01 · FY2009 · ES
Translating gene-calcium interactions to precision medicine for colorectal cancer
$374,455Qi Dai · Vanderbilt University Medical Center · U01 · FY2019 · CA
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
$374,453Roswell Park Cancer Institute Corp · R01 · FY2004 · CA
Targeting androgen receptor nuclear localization in prostate cancer
$374,450Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Targeting androgen receptor nuclear localization in prostate cancer
$374,450Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$374,436Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · CA
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$374,388Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · CA
Programmable transdermal drug delivery
$374,384Micah Yairi · Los Gatos Research · R44 · FY2010 · AR
Programmable transdermal drug delivery
$374,384Manish Gupta · Los Gatos Research · R44 · FY2011 · AR
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer
$374,383Don X Nguyen · Yale University · R01 · FY2014 · CA
Role of JMJD1A modifications in castration resistance of prostate cancer
$374,346Jianfei Qi · University Of Maryland Baltimore · R01 · FY2022 · CA
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$374,307Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2019 · CA
Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy
$374,305Goutham Narla · Case Western Reserve University · R01 · FY2017 · CA
Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy
$374,305Goutham Narla · Case Western Reserve University · R01 · FY2016 · CA
Project 1 High-order assembly of MegaTrans complexes for hormone-independent enhancer activation
$374,247Zhijie "jason" Liu · University Of Texas Hlth Science Center · U54 · FY2019 · CA
Regulation of Metastatic Development by Heritable Variants in the Tumor Microenvironment
$374,245Paula Jill Hurley · Johns Hopkins University · R01 · FY2018 · CA